Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Objective: To determine whether treatment in a private versus public hospital was an independent predictor of survival outcomes in patients with colorectal cancerDesign: Retrospective, population-based study.Setting: Tertiary care hospitals.Participants: All patients diagnosed with colorectal cancer in Western Australia between 1993 and 2003.Interventions: Management in private versus public hospitals.Main outcome measures: Overall survival and cancer-specific survival rates.Results: 5809 patients were treated for colorectal cancer. Of these, 1523 (26%) were managed in private hospitals. The 5-year overall survival rates for private and public hospital patients were 59.4% (95% CI, 56.9%-61.9%) and 48.6% (95% CI, 47.0%-50.2%), respectively. Significant independent predictors of overall survival were: treatment in a, private hospital (P = 0.0001; relative risk [RR], 0.764; 95% Cl, 0.696-0.839); younger age (P=0.0001; RR, 1.032; 95% CI, 1.029-1.036); male sex (P=0.001; RR, 1.148; 95% Cl, 1.068-1.234); and cancer stage (eg, Stage II: P=0.0001; RR, 1.508; 95% CI, 1.316-1.729).Conclusions: Treatment in a private hospital was a significant independent predictor of survival outcomes. Further validation of these results would have a significant bearing on how we approach health care delivery for patients with colorectal cancer.
Original languageEnglish
Pages (from-to)296-300
JournalMedical Journal of Australia
Volume186
Issue number6
Publication statusPublished - 2007

Fingerprint

Private Hospitals
Public Hospitals
Colorectal Neoplasms
Survival
Survival Rate
Western Australia
Tertiary Healthcare
Tertiary Care Centers
Neoplasms
Therapeutics
Outcome Assessment (Health Care)
Delivery of Health Care
Population

Cite this

@article{81cdd6d52bd445b398033f2f2c5a3000,
title = "Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals",
abstract = "Objective: To determine whether treatment in a private versus public hospital was an independent predictor of survival outcomes in patients with colorectal cancerDesign: Retrospective, population-based study.Setting: Tertiary care hospitals.Participants: All patients diagnosed with colorectal cancer in Western Australia between 1993 and 2003.Interventions: Management in private versus public hospitals.Main outcome measures: Overall survival and cancer-specific survival rates.Results: 5809 patients were treated for colorectal cancer. Of these, 1523 (26{\%}) were managed in private hospitals. The 5-year overall survival rates for private and public hospital patients were 59.4{\%} (95{\%} CI, 56.9{\%}-61.9{\%}) and 48.6{\%} (95{\%} CI, 47.0{\%}-50.2{\%}), respectively. Significant independent predictors of overall survival were: treatment in a, private hospital (P = 0.0001; relative risk [RR], 0.764; 95{\%} Cl, 0.696-0.839); younger age (P=0.0001; RR, 1.032; 95{\%} CI, 1.029-1.036); male sex (P=0.001; RR, 1.148; 95{\%} Cl, 1.068-1.234); and cancer stage (eg, Stage II: P=0.0001; RR, 1.508; 95{\%} CI, 1.316-1.729).Conclusions: Treatment in a private hospital was a significant independent predictor of survival outcomes. Further validation of these results would have a significant bearing on how we approach health care delivery for patients with colorectal cancer.",
author = "Melinda Morris and Barry Iacopetta and Cameron Platell",
year = "2007",
language = "English",
volume = "186",
pages = "296--300",
journal = "Medical Journal Australia",
issn = "0025-729X",
publisher = "Australasian Medical Publishing Co. Ltd",
number = "6",

}

TY - JOUR

T1 - Comparing survival outcomes for patients with colorectal cancer treated in public and private hospitals

AU - Morris, Melinda

AU - Iacopetta, Barry

AU - Platell, Cameron

PY - 2007

Y1 - 2007

N2 - Objective: To determine whether treatment in a private versus public hospital was an independent predictor of survival outcomes in patients with colorectal cancerDesign: Retrospective, population-based study.Setting: Tertiary care hospitals.Participants: All patients diagnosed with colorectal cancer in Western Australia between 1993 and 2003.Interventions: Management in private versus public hospitals.Main outcome measures: Overall survival and cancer-specific survival rates.Results: 5809 patients were treated for colorectal cancer. Of these, 1523 (26%) were managed in private hospitals. The 5-year overall survival rates for private and public hospital patients were 59.4% (95% CI, 56.9%-61.9%) and 48.6% (95% CI, 47.0%-50.2%), respectively. Significant independent predictors of overall survival were: treatment in a, private hospital (P = 0.0001; relative risk [RR], 0.764; 95% Cl, 0.696-0.839); younger age (P=0.0001; RR, 1.032; 95% CI, 1.029-1.036); male sex (P=0.001; RR, 1.148; 95% Cl, 1.068-1.234); and cancer stage (eg, Stage II: P=0.0001; RR, 1.508; 95% CI, 1.316-1.729).Conclusions: Treatment in a private hospital was a significant independent predictor of survival outcomes. Further validation of these results would have a significant bearing on how we approach health care delivery for patients with colorectal cancer.

AB - Objective: To determine whether treatment in a private versus public hospital was an independent predictor of survival outcomes in patients with colorectal cancerDesign: Retrospective, population-based study.Setting: Tertiary care hospitals.Participants: All patients diagnosed with colorectal cancer in Western Australia between 1993 and 2003.Interventions: Management in private versus public hospitals.Main outcome measures: Overall survival and cancer-specific survival rates.Results: 5809 patients were treated for colorectal cancer. Of these, 1523 (26%) were managed in private hospitals. The 5-year overall survival rates for private and public hospital patients were 59.4% (95% CI, 56.9%-61.9%) and 48.6% (95% CI, 47.0%-50.2%), respectively. Significant independent predictors of overall survival were: treatment in a, private hospital (P = 0.0001; relative risk [RR], 0.764; 95% Cl, 0.696-0.839); younger age (P=0.0001; RR, 1.032; 95% CI, 1.029-1.036); male sex (P=0.001; RR, 1.148; 95% Cl, 1.068-1.234); and cancer stage (eg, Stage II: P=0.0001; RR, 1.508; 95% CI, 1.316-1.729).Conclusions: Treatment in a private hospital was a significant independent predictor of survival outcomes. Further validation of these results would have a significant bearing on how we approach health care delivery for patients with colorectal cancer.

M3 - Article

VL - 186

SP - 296

EP - 300

JO - Medical Journal Australia

JF - Medical Journal Australia

SN - 0025-729X

IS - 6

ER -